4th Cytokine-Based Drug Development Summit

Be part of the only industry focused event exclusively addressing discovery, translational and reverse translational challenges for Cytokine-Based drug developers.

View the full program and speaker faculty here.

With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand and build on the current potential of cytokine-based drugs.

Across 3 days of unparalleled content, showcasing companies including Moderna, Sanofi, Orionis Biosciences, CytomX Therapeutics and others in the clinic, this conference will provide a deep dive into the exciting new applications of engineered interleukins (IL-2, IL-12 and IL-15). In addition, your peers will be addressing industry’s most pressing toxicity issues across other cytokines (TGF-β, IL-7) and much more to accelerate the development of cytokines with a widened therapeutic index.

Take a look at your dedicated agenda exploring Cytokine biology, how to avoid a Cytokine storm and optimizing cytokine combination studies to bring improved cytokine therapies to patients.

To get the best registration rates, book your place early.